YIFAN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.47 CNY | +3.92% |
|
+0.89% | -15.63% |
| 06-04 | Yifan Pharmaceutical Gets Nod to Register Phloroglucinol Injection | MT |
| 05-14 | Yifan Pharmaceutical Unit Gets Authorization to Sell Circulation Supplement in Singapore | MT |
ETFs positioned on Yifan Pharmaceutical Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 35 M€ | +6.70% | - | |
| 0.00% | 32 M€ | +4.91% | - |
Yifan Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production, sales and pharmaceutical promotion services of pharmaceutical products, active pharmaceutical ingredient and polymer materials. The Company conducts business through two segments. The Pharmaceutical Products segment mainly produces Chinese patent medicines, chemical drugs and biological drugs. Its products include Child Qingqiao Granules, Skin Allery Relieving Capsules, lactulose oral solution and granulocyte colony stimulating factor. The Pharmaceutical Raw Materials and Polymers segment mainly produces active pharmaceutical ingredient, and its products are mainly vitamin B5 and pro-B5. The Company mainly conducts business in domestic and foreign markets.
Sector
Pharmaceuticals
Calendar
2024-08-14
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.47
CNY
Average target price
19
CNY
Spread / Average Target
+52.37%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.63% | 2.09B | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +15.99% | 320B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B |
- Stock Market
- Equities
- 002019 Stock
- ETFs Yifan Pharmaceutical Co., Ltd.
